Keratins and the keratinocyte activation cycle.

Area of Science:

• Dermatology
• Cell Biology
• Molecular Biology

Background:

• Keratinocytes undergo activation in wound healing and disease, exhibiting migratory and hyperproliferative properties.
• This activation involves cytoskeletal alterations, extracellular matrix production, and secretion of signaling molecules.
• Growth factors, chemokines, and cytokines orchestrate these cellular changes by influencing intracellular signaling pathways and gene expression.

Purpose of the Study:

• To propose and describe the keratinocyte activation cycle.
• To identify key molecular players and signaling pathways involved in keratinocyte activation.
• To elucidate the role of specific keratins (K6, K16, K17, K5, K14) as markers and mediators of keratinocyte states.

Main Methods:

• Analysis of keratinocyte signaling pathways and gene expression.
• Identification of keratin proteins associated with activated keratinocytes.
• Investigation of the roles of Interleukin-1 (IL-1), Interferon-gamma (IFN-γ), and Transforming Growth Factor-beta (TGF-β) in regulating keratinocyte phenotype.

Main Results:

• Keratinocyte activation is proposed as a cycle initiated by IL-1.
• Autocrine signaling maintains the activated state, with keratins K6 and K16 as markers.
• IFN-γ induces K17 expression and keratinocyte contractility for basement membrane remodeling.
• TGF-β induces K5 and K14 expression, reverting cells to a basal phenotype, thus completing the cycle.

Conclusions:

• The keratinocyte activation cycle is a dynamic process involving distinct cellular and molecular events.
• Specific keratins serve as crucial markers and functional components throughout the activation cycle.
• Interplay between immune cells (lymphocytes) and stromal cells (fibroblasts) regulates keratinocyte behavior during tissue repair and pathology.